![]() Jiyoung Ahn, PhD New York University Oral Microbiome and Pancreatic Cancer: A Prospective Case-Control Study |
![]() David Boothman, PhD UT Southwestern Medical Center NQO1-mediated ‘Kiss of death’ Targeted Therapy for Pancreatic Cancer |
![]() Darren Carpizo, MD, PhD Rutgers Cancer Institute of New Jersey, Rutgers University Pre-clinical Studies of an Allele-Specific p53 Mutant Reactivating Compound in Pancreatic Cancer |
![]() Paul Chiao, PhD MD Anderson Cancer Center TAK1 is a Novel Therapeutic Target in Pancreatic Cancer |
![]() Eric Collisson, MD 大学of California, San Francisco Optimizing MEK Inhibition in Pancreatic Cancer; from Cytostatic to Cidal |
![]() Channing Der, PhD 大学of North Carolina Mechanism of ERK Inhibition Resistance and ERK-dependent Pancreatic Cancer |
![]() Stephanie Dougan, PhD Whitehead Institute for Biomedical Research Transnuclear mice: understanding the T cell response to pancreatic cancer |
![]() Mikala Egeblad, PhD Cold Spring Harbor Laboratory Dynamics of Tumor-Stroma Interactions in Pancreatic Cancer |
![]() Peter Espenshade, PhD Johns Hopkins University SREBP Pathway as a Target for Pancreatic Cancer Therapy |
![]() Tyler Jacks, PhD Massachusetts Institute of Technology Mechanisms of K-RAS Independent Growth in Pancreatic Cancer |
![]() Florencia McAllister, MD Johns Hopkins University Role of Inflammatory Cells in Early Pancreatic Tumorigenesis |
![]() Oliver McDonald, MD, PhD Johns Hopkins University Genome-wide epigenetic reprogramming during evolution of pancreatic cancer |
![]() Kazuki Sugahara, MD, PhD Sanford-Burnham Medical Research Institute Tissue-Penetrating Drug Delivery to Desmoplastic Pancreatic Tumors |
![]() David Sung-wen Yu, MD, PhD Emory University Exploiting the Replication Stress Response in Pancreatic Cancer |